BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8589 related articles for article (PubMed ID: 18756968)

  • 1. [The relationship between Fas/FasL and proliferating cell nuclear antigen expression and malignant degree in human melanoma].
    Wang YC; Tan Y
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):965-8. PubMed ID: 18756968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
    Shukuwa T; Katayama I; Koji T
    Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAS, FAS ligand, tumor infiltrating lymphocytes, and macrophages in malignant melanoma: an immunohistochemical study.
    Bozdogan N; Bozdogan O; Pak I; Atasoy P
    Int J Dermatol; 2010 Jul; 49(7):761-7. PubMed ID: 20618494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of potassium channel on the proliferation, apoptosis and related-gene expression in human bronchial smooth muscle cells].
    Zhao LM; Xu YJ; Zhang ZX; Ni W; Chen SX
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):841-6. PubMed ID: 15730786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCNA expression and nucleolar organizer regions in malignant melanoma and nevus cell nevus.
    Kanoko M; Ueda M; Ichihashi M
    Kobe J Med Sci; 1994 Aug; 40(3-4):107-23. PubMed ID: 7739200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of heat shock protein 105 and 70 in malignant melanoma and benign melanocytic nevi.
    Park HS; Park CH; Choi BR; Lim MS; Heo SH; Kim CH; Kang SG; Whang KU; Cho MK
    J Cutan Pathol; 2009 May; 36(5):511-6. PubMed ID: 19476517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative activity of primary cutaneous melanocytic tumours.
    Kuwata T; Kitagawa M; Kasuga T
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):359-64. PubMed ID: 7906909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Fas ligand (CD95L) in primary malignant melanoma and melanoma metastases is associated with overall survival.
    Neuber K; Eidam B
    Onkologie; 2006 Sep; 29(8-9):361-5. PubMed ID: 16974112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
    Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
    Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of heat shock protein 105 in melanoma and melanocytic naevi.
    Muchemwa FC; Nakatsura T; Fukushima S; Nishimura Y; Kageshita T; Ihn H
    Melanoma Res; 2008 Jun; 18(3):166-71. PubMed ID: 18477890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The expression of proliferating cell nuclear antigen and p53 protein in salivary gland tumours].
    Tian Y; Wang Z; Zhong M
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 May; 32(3):177-9. PubMed ID: 10680534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proliferative characteristics of nevus in children with organ transplants].
    Kanitakis J; Euvrard S; Faure M; Claudy A
    Ann Dermatol Venereol; 1999 Oct; 126(10):687-90. PubMed ID: 10604005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of estrogen receptor beta in normal skin, melanocytic nevi and malignant melanomas.
    Ohata C; Tadokoro T; Itami S
    J Dermatol; 2008 Apr; 35(4):215-21. PubMed ID: 18419678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of galanin in melanocytic tumors].
    Gilaberte Y; Vera J; Coscojuela C; Roca MJ; Parrado C; González S
    Actas Dermosifiliogr; 2007; 98(1):24-34. PubMed ID: 17374330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleolin protein expression in cutaneous melanocytic lesions.
    Mourmouras V; Cevenini G; Cosci E; Epistolato MC; Biagioli M; Barbagli L; Luzi P; Mannucci S; Miracco C
    J Cutan Pathol; 2009 Jun; 36(6):637-46. PubMed ID: 19515042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: a case-control analysis.
    Zhang H; Sun XF; Synnerstad I; Rosdahl I
    Cancer J; 2007; 13(4):233-7. PubMed ID: 17762757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative activities in Spitz nevus compared with melanocytic nevus and malignant melanoma using expression of PCNA/cyclin and mitotic rate.
    Tu P; Miyauchi S; Miki Y
    Am J Dermatopathol; 1993 Aug; 15(4):311-4. PubMed ID: 8105711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER3 expression in cutaneous tumors.
    Wimmer E; Kraehn-Senftleben G; Issing WJ
    Anticancer Res; 2008; 28(2A):973-9. PubMed ID: 18507044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.
    Einspahr JG; Xu MJ; Warneke J; Saboda K; Ranger-Moore J; Bozzo P; Duckett L; Goldman R; Lin P; Buckmeier J; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1841-8. PubMed ID: 17021352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 430.